TWiV 908: Clinical update with Dr. Daniel Griffin

Published: Feb. 4, 2023, 5 a.m.

b'

In his weekly clinical update Dr. Griffin\\xa0discusses prevalence and clinical outcomes of respiratory syncytial virus versus influenza virus in adults hospitalized with acute respiratory Illness,\\xa0reconsideration of antinucleocapsid IgG antibody as a marker of SARS-CoV-2 infection postvaccination for mild COVID-19 patients,\\xa0assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US, information for persons who are immunocompromised regarding prevention and treatment of SARS-CoV-2 Infection in the context of currently circulating Omicron sublineages, association of culturable-virus detection and household transmission of SARS-CoV-2,\\xa0\\xa0effectiveness of bivalent boosters against severe Omicron infection,\\xa0Covid vaccines and playing the long game,\\xa0efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19, and\\xa0severe fatigue and persistent symptoms at three months following SARS-CoV-2 Infections during the pre-Delta, Delta, and Omicron time periods.

Subscribe (free):\\xa0Apple Podcasts,\\xa0Google Podcasts,\\xa0RSS,\\xa0email

Become a\\xa0patron\\xa0of\\xa0TWiV!

Intro music is by\\xa0Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

'